SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE.
ATRX 0.00010000.0%Aug 1 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patlew who wrote (54)2/27/1999 7:21:00 AM
From: Arthur Radley   of 182
 
Lloy,
I have never thought of Atridox as a monotherapy for periodontal disease. I think from the major discussions that I have seen, it has always been talked about by the dentist as a combination treatment. I see it as a great tool(method) of reducing the infected area so that SRP can be done in a more effective way.

I still feel very comfortable with the potential for Atridox. As you know, there are millions that suffer from this condition and aren't receiving any medical treatment for the problem.....all because of the pain issue related to SRP. At least Atridox now gives them a viable option.

Thanks for your comments. It is always appreciated to see opposing views as the trees often block the view of the forest.(:>)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext